1-866-647-3279

06

Aug 2026

Adverse Event Monitoring in Probiotic Clinical Trials: What Sponsors Need to Get Right
Adverse Event Monitoring in Probiotic Clinical Trials: What Sponsors Need to Get Right
By
At a Glance While many commercially available probiotics have a well-documented history of safe use in healthy populations, clinical trials evaluating live biotherapeutic products (LBPs) or probiotic dietary supplements are […] Read More >>
Dietary Supplement Labeling Act of 2013
November 24, 2013 By
The proposed Dietary Supplement Labeling Act of 2013 to amend the FFDCA and would require big changes to the industry, if the Act is passed.  On August 1, 2013 the […] Read More >>
The Importance of Tracking and Reporting Adverse and Serious Adverse Events to the FDA
February 11, 2013 By
FDA requires that all adverse and serious adverse events are tracked and reported, as required. Adverse event reporting is key area that inspectors focus on when inspecting a company. Tracking […] Read More >>
FDA’s Increasing Enforcement Activities Highlight the Importance of Regulatory Compliance with respect to Dietary Supplement Liability Insurance
January 28, 2013 By
By: Heather VanBlarcom General Counsel & Senior Regulatory Specialist for Dietary Supplements Although many companies are aware of the need to have dietary supplement liability insurance, it is also important […] Read More >>

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions